KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) FCF Margin: 2017-2024

Historic FCF Margin for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -3,563.29%.

  • Aquestive Therapeutics' FCF Margin fell 1228.00% to -100.60% in Q3 2025 from the same period last year, while for Sep 2025 it was 387.23%, marking a year-over-year increase of 44559.00%. This contributed to the annual value of -3,563.29% for FY2024, which is 354871.00% down from last year.
  • According to the latest figures from FY2024, Aquestive Therapeutics' FCF Margin is -3,563.29%, which was down 24,339.60% from -14.58% recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' FCF Margin registered a high of -14.58% during FY2023, and its lowest value of -3,563.29% during FY2024.
  • In the last 3 years, Aquestive Therapeutics' FCF Margin had a median value of -22.74% in 2022 and averaged -1,200.20%.
  • Per our database at Business Quant, Aquestive Therapeutics' FCF Margin spiked by 108,273bps in 2021 and then slumped by 354,871bps in 2024.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' FCF Margin stood at -1,149.40% in 2020, then soared by 108,273bps to -66.67% in 2021, then spiked by 4,393bps to -22.74% in 2022, then soared by 816bps to -14.58% in 2023, then slumped by 354,871bps to -3,563.29% in 2024.